Gujarat Terce Laboratories Limited (BOM:524314)

Market Cap	306.12M -4.0%
Revenue (ttm)	456.22M -9.1%
Net Income	20.67M
EPS	2.70
Shares Out	7.79M
PE Ratio	14.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	380
Open	41.00
Previous Close	36.02
Day's Range	39.29 - 41.80
52-Week Range	29.00 - 59.78
Beta	0.93
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, and Codimol brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is b...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 234
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524314

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 28, 2026

Data Sources Report a data error